Background: Emerging data suggest that coagulopathy, cytokine storm, and acute
respiratory distress syndrome are associated with the 2019 coronavirus disease (COVID …

Shortly after the emergence of coronavirus disease 2019 (COVID-19) in late 2019, clinicians
rapidly recognized an apparent association between the disease and both arterial and …

Background Observational studies have suggested a higher risk of thrombotic events in
patients with coronavirus disease 2019 (COVID-19). Moreover, elevated D-dimer levels …

Abstract Coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2), is a global public health concern and is …

There were initially three clear lines of evidence in support of an association between
thrombosis and coronavirus disease 2019 (COVID-19), as caused by SARS-CoV-2 (severe …

Abstract Corona virus 2 (SARS-CoV2/Severe Acute Respiratory Syndrome Corona Virus 2)
infection has emerged as a global health crisis. Incidence of thromboembolic disease is …

As the coronavirus disease 2019 (COVID-19) pandemic is evolving, coagulopathy induced
by the disease and its severe complications are raising concerns in the medical community …

Abstract Coronavirus disease 2019 (COVID-19) has been associated with an increased risk
of thromboembolic complications due to systemic coagulation activation. Little is known …

Abstract Coronavirus disease 19 (COVID-19) is a systematic multitropic disease. Sustaining
blood homeostasis is a mission of multiple factors includes procoagulant and anticoagulant …

The haemostatic profile in critically ill COVID-19 patients... : Medicine The haemostatic profile in
critically ill COVID-19 patients receiving therapeutic anticoagulant therapy: An observational …